Brewing Evidence for Pharmacotherapy in Dyskinetic Cerebral Palsy: A Step in the Right Direction
- PMID: 37277685
- DOI: 10.1007/s12098-023-04670-1
Brewing Evidence for Pharmacotherapy in Dyskinetic Cerebral Palsy: A Step in the Right Direction
Comment on
-
Gabapentin as Add-on Therapy to Trihexyphenidyl in Children with Dyskinetic Cerebral Palsy: A Randomized, Controlled Trial.Indian J Pediatr. 2023 Sep;90(9):873-879. doi: 10.1007/s12098-022-04265-2. Epub 2022 Jul 22. Indian J Pediatr. 2023. PMID: 35867274 Clinical Trial.
References
-
- Harvey AR, Baker LB, Reddihough DS, Scheinberg A, Williams K. Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database Syst Rev. 2018;5:CD012430. - PubMed
-
- Kumar S, Kaushik JS, Verma S, Dabla S. Gabapentin as add-on therapy to trihexyphenidyl in children with dyskinetic cerebral palsy: a randomized, controlled trial. Indian J Pediatr. 2022. https://doi.org/10.1007/s12098-022-04265-2 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical